What is the appropriate treatment for uncomplicated genital Chlamydia trachomatis infection in a 48-year-old homeless woman living in a shelter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Uncomplicated Chlamydia in a Homeless Woman

Give azithromycin 1 g orally as a single dose immediately, dispensed on-site with directly observed administration. 1, 2, 3

Why Single-Dose Azithromycin is Essential in This Case

For a homeless woman living in a shelter, azithromycin is strongly preferred over doxycycline because compliance with a 7-day regimen is unpredictable in populations with erratic health-care-seeking behavior. 1, 3 While both medications achieve 97-98% cure rates when compliance is ensured, the reality of homelessness makes follow-up and medication adherence extremely challenging. 1, 2, 4

Dispense the medication on-site and directly observe her taking the full 1 g dose before she leaves the clinic. 1, 3 This single intervention eliminates compliance concerns entirely and ensures treatment completion. 1

Alternative Only If Azithromycin Cannot Be Used

If azithromycin is contraindicated (documented severe allergy), use doxycycline 100 mg orally twice daily for 7 days, but recognize that treatment failure is more likely in this population due to adherence challenges. 5, 1, 6 The FDA-approved doxycycline regimen requires exactly 7 days—not shorter—to achieve the 95-98% cure rate. 6

Other alternatives (levofloxacin 500 mg daily for 7 days, ofloxacin 300 mg twice daily for 7 days, or erythromycin regimens) are inferior choices with lower efficacy (88-94% for levofloxacin), more side effects, higher cost, and no compliance advantage. 1, 3

Critical Management Steps

Sexual Activity Restrictions

She must abstain from all sexual intercourse for 7 full days after taking azithromycin and until all sex partners complete treatment. 1, 2, 3 Reinfection occurs in up to 20% of cases when partners are not treated. 1

Partner Management

All sex partners from the preceding 60 days must receive empiric treatment with the same regimen—azithromycin 1 g single dose—even if asymptomatic and without waiting for test results. 1, 2, 3 If her last sexual contact was more than 60 days ago, treat that most recent partner. 1

Consider expedited partner therapy (providing medication for partners) if direct partner evaluation is not feasible, which is common in homeless populations. 1

Additional STI Testing

Test her immediately for gonorrhea, syphilis, and HIV at this same visit. 1 Coinfection rates with gonorrhea are 20-40% in high-prevalence populations. 1 If gonorrhea prevalence is high (>5%) in your clinic population or if testing is unavailable, treat presumptively for both infections with ceftriaxone 250 mg IM single dose PLUS azithromycin 1 g orally single dose. 1, 3

Follow-Up Protocol

No Test-of-Cure Needed

Do not perform test-of-cure after azithromycin treatment unless she remains symptomatic or reinfection is suspected. 1, 2, 3 Treatment failure rates with azithromycin are only 0-8%, making routine retesting wasteful. 3 Testing before 3 weeks post-treatment yields false-positives from dead organism DNA. 1, 3

Mandatory Reinfection Screening

Schedule her to return in 3 months for repeat chlamydia testing, regardless of whether partners were reportedly treated. 1, 2, 3 Reinfection rates reach 39% in some populations, and repeat infections carry elevated risk for pelvic inflammatory disease, ectopic pregnancy, and infertility. 1, 3 This 3-month retest is distinct from test-of-cure and screens for new exposure. 1

Common Pitfalls to Avoid

  • Do not prescribe doxycycline for 7 days and expect compliance in a homeless patient—you are setting her up for treatment failure. 1, 3
  • Do not wait for test results before treating partners—empiric partner treatment prevents the 20% reinfection rate. 1
  • Do not assume partners were treated based on patient report—directly verify or use expedited partner therapy. 1
  • Do not perform test-of-cure at 1-2 weeks—nucleic acid tests will be falsely positive from residual DNA. 1, 3
  • Do not skip the 3-month reinfection screen—this is when you will detect clinically significant reinfections that increase PID risk. 1, 3

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.